Our products are designed to support and improve treatment outcomes in the areas of eye care, wound and skin care, nasal care and the symptoms of the common cold.
The incidence and prevalence of chronic disease is a leading cause of morbidity. At Melcare, we are experts in the development of products to help relieve some of the symptoms associated with chronic disease.
Melcare President, Anthony Moloney, is a leading developer of innovative therapeutic products.
Since 1992, his research and development has focused on solutions for chronic conditions, leading to the development of the pioneering Medihoney® wound and burns care products (1999), the Melcare brand of products (2009), and the specialized Optimel® eye care range (2012).